Results 131 to 140 of about 32,692 (251)

Physical characterization of HNSCC cells [PDF]

Laryngo-Rhino-Otologie, 2019
J Kristin, M Strugacevac, HC Tsai, N Ullrich, C Wiek, J Schipper, M Getzlaff   +6 more
openaire   +1 more source

Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions

Head &Neck, Volume 48, Issue 9, Page 2584-2592, September 2026.
ABSTRACT Background Head and neck squamous cell carcinoma (HNSCC) is frequently diagnosed at advanced stages and has historically been associated with poor outcomes. Immune checkpoint inhibition has transformed the therapeutic landscape, offering durable responses in recurrent, metastatic, and locally advanced disease.
Carol R. Bradford, Sreeram M. P., Karthik N. Rao, Orlando Guntinas‐Lichius, Nabil Saba, Alfio Ferlito   +5 more
wiley   +1 more source

From Berry to Bedside: Translational Potential of Berry-Derived Phytochemicals in HNSCC. [PDF]

Molecules
Nyati KK, Ramalingam R, Shrestha S, Jagadeesha S, Dasari S, Masood S, Yade M, Mehta PA, Kundety S, Oghumu S.   +9 more
europepmc   +1 more source

Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium

International Journal of Cancer, Volume 159, Issue 5, Page 1204-1217, 1 September 2026.
Tobacco use and alcohol consumption are primary risk factors for head and neck squamous cell carcinoma, with combined use occurring in three‐quarters of cases. This large international study of former smokers shows that the risk reduction effect of smoking cessation occurs more slowly for laryngeal cancer than for other head and neck cancer subsites ...
Matheus de Abreu, Luiz Paulo Kowalski, Rossana Mendoza López, Christine Barul, Loredana Radoi, Ettore Bidoli, Jerry Polesel, Victor Wunsch‐Filho, Andrew F. Olshan, Jose Zevallos, Eva Negri, Valeria Edefonti, Beata Świątkowska, Dana Mates, Eleonora Fabianova, Jolanta Lissowska, Oxana Shangina, Paul Brennan, Tamas Pandics, Luigino Dal Maso, Hal Morgenstern, Zuo‐Feng Zhang, Karl Kelsey, Michael McClean, Carlo La Vecchia, Werner Garavello, Chu Chen, Stephen M. Schwartz, Heribert Ramroth, Volker Winkler, Gabriella Cadoni, Stefania Boccia, Hermann Brenner, Gypsyamber D'Souza, Neil Gross, Joshua Muscat, Mahsa Abedini, Michele Sassano, Paolo Boffetta, Mia Hashibe, Yuan‐Chin Amy Lee, Maria Paula Curado   +41 more
wiley   +1 more source

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. [PDF]

Oncol Rev
Alabbasi A, Alzahrani M, Alzahrani Z, Sultan F, AlQahtani M, Sultan A.   +5 more
europepmc   +1 more source

Nanomaterial‐Mediated Radiotherapy–Immunotherapy Combinations: Breaking Immunosuppression and Revolutionizing Cancer Treatment

MedComm – Biomaterials and Applications, Volume 5, Issue 3, September 2026.
Nanomaterials integrate radiotherapy and immunotherapy by enhancing radiosensitivity, remodeling the immunosuppressive tumor microenvironment, and promoting systemic antitumor immunity. This review summarizes the latest strategies of nanomaterial‐mediated combinations (RT, immunotherapy, IRT) and highlights future directions for overcoming clinical ...
Peijie Li, Xiangqin Wang, Sisi He, Hu Ma
wiley   +1 more source

Clinical and economic burden of recurrence among older patients with locoregionally advanced head and neck squamous cell carcinoma in the United States. [PDF]

J Manag Care Spec Pharm
Zheng D, Zhang S, Bidadi B, Lerman N, Song Y, Tang Y, Song R, Li J, Zhu A, Signorovitch J, Merchant S, Hanna GJ.   +11 more
europepmc   +1 more source

Hypoxia Induces a Mitotic Survival Advantage After Radiotherapy in Head and Neck Cancer Cells

International Journal of Cancer, Volume 159, Issue 4, Page 1042-1055, 15 August 2026.
Hypoxic tumor environments significantly limit radiotherapy effectiveness against cancer, particularly in head and neck squamous cell carcinoma (HNSCC). Here, the authors tracked hypoxic and post‐hypoxic cells using a hypoxia‐fate mapping system in human papillomavirus (HPV)‐positive and HPV‐negative HNSCC models.
Marilyn Wegge, Rüveyda Dok, Ludwig J. Dubois, Sandra Nuyts   +3 more
wiley   +1 more source

Basic and Clinical Evidence for Perioperative Immunotherapy in Resectable HNSCC. [PDF]

Cancers (Basel)
Sakaue S, Kono M, Kumai T, Inoue T, Ominato H, Takahara M.   +5 more
europepmc   +1 more source

HNRNPD Induces Radioresistance in Nasopharyngeal Carcinoma by Sequestering GRAMD4 mRNA in Stress Granules

Advanced Science, Volume 13, Issue 43, 3 August 2026.
HNRNPD promotes radioresistance in nasopharyngeal carcinoma by enhancing stress granule assembly and sequestering GRAMD4 mRNA. This suppresses GRAMD4 translation and inhibits mitochondrial apoptosis. Targeting the integrated stress response with ISRIB restores GRAMD4 expression and sensitizes tumors to radiotherapy, revealing a translational control ...
Yingzi Li, Tong Xiang, Yuanyuan Liu, Desheng Weng, Jingjing Zhao, Hao Chen, Yan Tang, Songzuo Xie, Hao Zhang, Jun Luo, Xinyi Yang, Qiuzhong Pan, Muping Di, Jianchuan Xia   +13 more
wiley   +1 more source